The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenalytix Plc Regulatory News (RENX)

Share Price Information for Renalytix Plc (RENX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 26.50
Bid: 26.00
Ask: 27.00
Change: 0.00 (0.00%)
Spread: 1.00 (3.846%)
Open: 26.50
High: 26.50
Low: 26.50
Prev. Close: 26.50
RENX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Renalytix plc

22 Mar 2024 08:37

Form 8.5 (EPT/RI) - Renalytix plc

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Name of exempt principal trader:Investec Bank plc
(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeRenalytix plc
(c) Name of the party to the offer with which exempt principal trader is connected:Investec is Joint Broker to Renalytix plc
(d) Date dealing undertaken: 21st March 2024
(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer? If it is a cash offer or possible cash offer, state “N/A” N/A

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchases/ sales Total number of securitiesHighest price per unit paid / received (pence)Lowest price per unit paid / received (pence)
Ordinary Shares Purchases 15,000 34.75 34.75

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
     

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
        

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
     

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
    

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
 

Date of disclosure:22nd March 2024
Contact name:Jacq Lovis
Telephone number:+44 207 597 4815

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at.

Date   Source Headline
15th Mar 20242:42 pmRNSForm 8.3 - Renalytix plc
15th Mar 20241:36 pmRNSForm 8.3 - Renalytix PLC
15th Mar 202412:05 pmRNSForm 8 (DD) - Renalytix Plc
15th Mar 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
15th Mar 202410:23 amRNSForm 8.3 - Renalytix PLC - Replacement
15th Mar 20247:27 amGNWForm 8.5 (EPT/RI) - Renalytix plc
15th Mar 20247:00 amRNSRule 2.9 announcement
14th Mar 20244:38 pmPRNForm 8.3 - Renalytix Plc
14th Mar 20244:03 pmPRNForm 8.3 - Renalytix Plc
14th Mar 20243:38 pmRNSForm 8 (DD) - Renalytix Plc
14th Mar 202412:02 pmRNSForm 8 (OPD)
14th Mar 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
14th Mar 202410:42 amRNSAmendment Form 8.5 (EPT/RI) - Renalytix plc
14th Mar 20247:32 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
14th Mar 20247:00 amRNSKidneyIntelXâ„¢ included in KDIGO 2024 Guideline
13th Mar 20247:24 pmPRNForm 8.3 - Renalytix Plc
13th Mar 20246:14 pmRNSForm 8.3 - RENALYTIX PLC
13th Mar 20243:22 pmPRNForm 8.3 - Renalytix Plc
13th Mar 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
13th Mar 20247:43 amGNWForm 8.5 (EPT/RI) - Renalytix plc
12th Mar 20243:31 pmRNSSuccessful completion of upsized $12m placing
12th Mar 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
12th Mar 20247:59 amGNWForm 8.5 (EPT/RI) - Renalytix plc
12th Mar 20247:00 amRNSLaunch of equity placing of approximately US$10m
11th Mar 20245:24 pmRNSForm 8.3 - Renalytix Plc
11th Mar 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
11th Mar 20248:10 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
8th Mar 202412:14 pmRNSFORM 8 (OPD) - Renalytix plc
8th Mar 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
8th Mar 202410:57 amRNSForm 8.3 - Renalytix Plc
8th Mar 20247:37 amGNWForm 8.5 (EPT/RI) - Renalytix plc
7th Mar 20248:06 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
6th Mar 20245:37 pmRNSForm 8.3 - RENALYTIX PLC
6th Mar 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
6th Mar 20247:56 amGNWForm 8.5 (EPT/RI) - Renalytix plc
5th Mar 20243:20 pmPRNForm 8.3 - Renalytix Plc
5th Mar 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
5th Mar 20248:08 amGNWForm 8.5 (EPT/RI) - Renalytix plc
4th Mar 20241:59 pmRNSForm 8.3 - Renalytix plc
4th Mar 20247:00 amRNSApproach from Possible Strategic Acquiror
1st Mar 20246:24 pmRNSGrant of Share Options - replacement
29th Feb 20247:00 amRNSUS Government coverage expanded
15th Feb 20247:00 amRNSHalf Year Report
9th Feb 20242:00 pmRNSRenalytix to Participate in the BTIG Conference
9th Feb 20247:00 amRNSCMS publishes Draft Local Coverage Determination
17th Jan 20247:00 amRNSUpdate on kidneyIntelX.dkd LCD Consideration
10th Jan 20247:00 amRNSNew published data for KidneyIntelXâ„¢
18th Dec 20237:00 amRNSIssue of Shares
15th Dec 20236:17 pmRNSResult of AGM
8th Dec 20236:14 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.